Axon Medical Technologies
Axon Medical Technologies is dedicated to advancing healthcare through innovative, non-invasive neurological assessment devices and platforms. Led by CEO and Chief Scientific Officer Michael Zarreii, the company develops FDA-registered tools like ECAT™ and Intellig-EYES™ to enable early detection and treatment of neurodegenerative diseases, brain injuries, and cognitive impairments. Their mission is to revolutionize diagnostics and improve patient outcomes with portable, accurate, and accessible technology.
Industries
Nr. of Employees
small (1-50)
Axon Medical Technologies
608 Market St. Suite 3, New Cumberland, PA 17070
Products
Cognitive assessment platform (objective + subjective)
An integrated assessment platform combining a short-duration objective ocular/pupillometry scan with established subjective cognitive tests to generate clinician-ready reports and baseline data for longitudinal tracking.
Head-mounted ocular sensor hardware
Lightweight, portable headgear used to perform objective pupillometry and ocular motor testing; designed for clinic and field use with rapid setup.
Cognitive assessment platform (objective + subjective)
An integrated assessment platform combining a short-duration objective ocular/pupillometry scan with established subjective cognitive tests to generate clinician-ready reports and baseline data for longitudinal tracking.
Head-mounted ocular sensor hardware
Lightweight, portable headgear used to perform objective pupillometry and ocular motor testing; designed for clinic and field use with rapid setup.
Services
Onsite patient assessments that combine a brief objective ocular/pupillometry scan with standard subjective cognitive tests; data uploaded to a secure server for physician review. Assessments are billed using established CPT codes and covered by Medicare/CMS where applicable.
Leasing program for deployment of head-mounted pupillometry hardware and associated software, with low monthly fees and per-scan billing options to reduce provider capital burden.
Training programs and complimentary certification enabling non-physician clinic staff to operate the assessment workflow and perform scans.
Registration service for physicians to join the provider/referral network and receive referrals once validated and equipped to offer the assessment.
Onsite patient assessments that combine a brief objective ocular/pupillometry scan with standard subjective cognitive tests; data uploaded to a secure server for physician review. Assessments are billed using established CPT codes and covered by Medicare/CMS where applicable.
Leasing program for deployment of head-mounted pupillometry hardware and associated software, with low monthly fees and per-scan billing options to reduce provider capital burden.
Training programs and complimentary certification enabling non-physician clinic staff to operate the assessment workflow and perform scans.
Registration service for physicians to join the provider/referral network and receive referrals once validated and equipped to offer the assessment.
Expertise Areas
- Cognitive assessment and diagnostics
- Pupillometry and ocular neurological measurement
- Early detection of neurodegenerative decline
- Clinical deployment and staff certification
Key Technologies
- Pupillometry
- Eye-tracking / ocular motor measurement
- Automated cognitive test integration
- Cloud-based secure data upload and review
News & Updates
Chief Science Officer Michael Zarreii expressed excitement following Pennsylvania Governor Tom Wolf’s signing of House Bill 1082, supporting early detection of memory loss and neurodegenerative diseases.
Physicians now have access to a new, non-invasive device for cognitive assessments that can be used anywhere with an internet connection.
The ECAT™ platform offers early detection and treatment options for patients at risk of neurodegenerative diseases.
Discusses the importance of early detection of memory issues and the potential for early intervention to improve quality of life.
Explains the difference between normal forgetfulness and serious memory loss, and when to seek medical advice.
Patents in Neurological Assessment Technologies
Multiple patents awarded for innovative non-invasive pupillometry and cranial nerve measurement technologies.
Chief Science Officer Michael Zarreii expressed excitement following Pennsylvania Governor Tom Wolf’s signing of House Bill 1082, supporting early detection of memory loss and neurodegenerative diseases.
Physicians now have access to a new, non-invasive device for cognitive assessments that can be used anywhere with an internet connection.
The ECAT™ platform offers early detection and treatment options for patients at risk of neurodegenerative diseases.
Discusses the importance of early detection of memory issues and the potential for early intervention to improve quality of life.
Explains the difference between normal forgetfulness and serious memory loss, and when to seek medical advice.
Patents in Neurological Assessment Technologies
Multiple patents awarded for innovative non-invasive pupillometry and cranial nerve measurement technologies.